333 related articles for article (PubMed ID: 26492593)
1. Statins and myositis: the role of anti-HMGCR antibodies.
Selva-O'Callaghan A; Alvarado-Cardenas M; Marin A; Pinal-Fernandez I
Expert Rev Clin Immunol; 2015; 11(12):1277-9. PubMed ID: 26492593
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune necrotising myopathy and HMGCR antibodies.
Karunaratne K; Amiras D; Pickering MC; Hofer M; Viegas S
Pract Neurol; 2018 Apr; 18(2):151-155. PubMed ID: 29439058
[TBL] [Abstract][Full Text] [Related]
3. Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.
Selva-O'Callaghan A; Alvarado-Cardenas M; Pinal-Fernández I; Trallero-Araguás E; Milisenda JC; Martínez MÁ; Marín A; Labrador-Horrillo M; Juárez C; Grau-Junyent JM
Expert Rev Clin Immunol; 2018 Mar; 14(3):215-224. PubMed ID: 29473763
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
Mammen AL; Chung T; Christopher-Stine L; Rosen P; Rosen A; Doering KR; Casciola-Rosen LA
Arthritis Rheum; 2011 Mar; 63(3):713-21. PubMed ID: 21360500
[TBL] [Abstract][Full Text] [Related]
5. Immune-mediated necrotizing myopathy associated with statins: history and recent developments.
Tiniakou E; Christopher-Stine L
Curr Opin Rheumatol; 2017 Nov; 29(6):604-611. PubMed ID: 28857949
[TBL] [Abstract][Full Text] [Related]
6. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA
Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376
[TBL] [Abstract][Full Text] [Related]
7. Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.
Liang WC; Uruha A; Suzuki S; Murakami N; Takeshita E; Chen WZ; Jong YJ; Endo Y; Komaki H; Fujii T; Kawano Y; Mori-Yoshimura M; Oya Y; Xi J; Zhu W; Zhao C; Watanabe Y; Ikemoto K; Nishikawa A; Hamanaka K; Mitsuhashi S; Suzuki N; Nishino I
Rheumatology (Oxford); 2017 Feb; 56(2):287-293. PubMed ID: 27818386
[TBL] [Abstract][Full Text] [Related]
8. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
Shovman O; Gilburd B; Chayat C; Lazar AD; Amital H; Blank M; Bentow C; Mahler M; Shoenfeld Y
Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830
[TBL] [Abstract][Full Text] [Related]
9. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
10. More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
Tiniakou E; Pinal-Fernandez I; Lloyd TE; Albayda J; Paik J; Werner JL; Parks CA; Casciola-Rosen L; Christopher-Stine L; Mammen AL
Rheumatology (Oxford); 2017 May; 56(5):787-794. PubMed ID: 28096458
[TBL] [Abstract][Full Text] [Related]
11. Anti-HMGCR Myopathy.
Mohassel P; Mammen AL
J Neuromuscul Dis; 2018; 5(1):11-20. PubMed ID: 29480216
[TBL] [Abstract][Full Text] [Related]
12. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
[TBL] [Abstract][Full Text] [Related]
13. Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin-Associated Immune-Mediated Necrotizing Myopathy: A Case Series.
Tiniakou E; Rivera E; Mammen AL; Christopher-Stine L
Arthritis Rheumatol; 2019 Oct; 71(10):1723-1726. PubMed ID: 31058470
[TBL] [Abstract][Full Text] [Related]
14. Statin-associated autoimmune myopathy: A distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories.
Alvarado-Cardenas M; Marin-Sánchez A; Martínez MA; Martínez-Martínez L; Pinal-Fernandez I; Labrador-Horrillo M; Balada E; Mundet-Tuduri X; Gonzalez-Mera L; Casademont J; Acebes EM; Moreno PJ; Juarez C; Grau-Junyent JM; Pujol-Borrell R; Selva-O'Callaghan A
Autoimmun Rev; 2016 Dec; 15(12):1161-1166. PubMed ID: 27640317
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous symptomatic improvement in a pediatric patient with anti-3-hydroxy-3-methylglutraryl-coenzyme A reductase myopathy.
Suárez B; Jofré J; Lozano-Arango A; Ortega X; Diaz J; Calcagno G; Bevilacqua JA; Castiglioni C
Neuromuscul Disord; 2020 Jun; 30(6):503-509. PubMed ID: 32518057
[TBL] [Abstract][Full Text] [Related]
16. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
Aggarwal R; Moghadam-Kia S; Lacomis D; Malik A; Qi Z; Koontz D; Burlingame RW; Oddis CV
Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
[No Abstract] [Full Text] [Related]
17. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of immune-mediated necrotizing myopathies and their treatments.
Pinal-Fernandez I; Mammen AL
Curr Opin Rheumatol; 2016 Nov; 28(6):619-24. PubMed ID: 27607340
[TBL] [Abstract][Full Text] [Related]
19. Mushroom supplements triggering a flare of HMGCR immune mediated necrotising myopathy.
Adler B; Christopher-Stine L; Tiniakou E
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35606030
[TBL] [Abstract][Full Text] [Related]
20. Mitophagy in three cases of immune-mediated necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: ultrastructural and immunohistochemical studies.
Matsubara S; Bokuda K; Asano Y; Morishima R; Sugaya K; Miyamoto K; Koide R; Komori T; Suzuki S; Nishino I
Neuromuscul Disord; 2018 Mar; 28(3):283-288. PubMed ID: 29402601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
